GL1X · GenesisL1 explorer

MolNFT v1 · #104677 · protein

Crystal structure of human dihydrofolate reductase as complex with pyridopyrimidine 22 (N~6~-methyl-N~6~-[4-(propan-2-yl) PHENYL]PYRIDO[2,3-D]PYRIMIDINE-2,4,6-triamine)

4QHV: “Crystal structure of human dihydrofolate reductase as complex with pyridopyrimidine 22…”. X-ray diffraction, 3 ligands (NDP, IXF, SO4), 1 pocket (best druggability 0.72). MolNFT v1 #104677 on GenesisL1: 3D structure, binding sites…

PDB
4QHV
Type
protein
Length
186 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydrofolate reductase
EC
1.5.1.3
UniProt
P00374
Ligands
NDP, IXF, SO4
Pockets
1 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 22% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydrofolate reductase (EC 1.5.1.3)protein18622% helix, 34% strandP00374

Ligands and binding sites

  • NDP · Nadph dihydro-nicotinamide-adenine-dinucleotide phosphate · ligand · chains A
  • IXF · N~6~-methyl-N~6~-[4-(propan-2-yl)phenyl]pyrido[2,3-d]pyrimidine-2,4,6-triamine · ligand · chains A
  • SO4 · Sulfate ion · ion · 6 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14780.720.8148NDP, IXF, SO4

Compared structures

  • 4QHV · Crystal structure of human dihydrofolate reductase as complex with pyridopyrimidine 22… · the same entry in another collection · chain A against A, TM-score 1.00
  • P00374 · AlphaFold monomer V2.0 prediction for dihydrofolate reductase (P00374) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.